IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis

International Immunology

Volumn 15, Issue 11, 2003, Pages 1283-1289

  Weir, Catherine ^a   Bernard, Claude C A ^b   Bäckström, B Thomas ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis; IL 5; Multiple sclerosis; Th1; Th2

Indexed keywords

ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNIZATION; IMMUNOCOMPETENCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIMED LYMPHOCYTE TYPING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; INTERFERON TYPE II; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0242468114     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg127     Document Type: Article

References (42)

1. Bernard, C. C., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J. and Bettadapura, J. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75:77.
2. Marmont, A. M. 1994. Defining criteria for autoimmune diseases. Immunol. Today 15:388.
3. Dittel, B. N., Visintin, I., Merchant, R. M. and Janeway, C. A., Jr. 1999. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163:32.
4. Legge, K. L., Gregg, R. K., Maldonado-Lopez, R., Li, L., Caprio, J. C., Moser, M. and Zaghouani, H. 2002. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196:217.
5. Weir, C. R., Nicolson, K. and Bäckström, B. T. 2002. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptice. Immunol. Cell Biol. 80:14.
6. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
7. + T cells. Immunol. Rev. 123:209.
8. Abbas, A. K., Murphy, K. M. and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
9. Smith, M. E. and Hoerner, M. T. 2000. Astrocytes modulate macrophage phagocytosis of myelin in vitro. J. Neuroimmunol. 102:154.
10. Traugott, U., McFarlin, D. E. and Raine, C. S. 1986. Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell. Immunol. 99:395.
11. Sriram, S., Solomon, D., Rouse, R. V. and Steinman, L. 1982. Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J. Immunol. 129:1649.
12. Myers, K. J., Sprent, J., Dougherty, J. P. and Ron, Y. 1992. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1.
13. h2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL. J. Neuroimmunol. 48:213.
14. h2-mediated pathologies in autoimmunity. J. Immunol. 167:3074.
15. h2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
16. Linington, C., Berger, T., Perry, L., Weerth, S., Hinze-Selch, D., Zhang, Y., Lu, H. C., Lassmann, H. and Wekerle, H. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
17. Kennedy, M. K., Torrance, D. S., Picha, K. S. and Mohler, K. M. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
18. Khoury, S. J., Hancock, W. W. and Weiner, H. L. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
19. Falcone, M., Rajan, A. J., Bloom, B. R. and Brosnan, C. F. 1998. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 160:4822.
20. Bettelli, E., Das, M. P., Howard, E. D., Weiner, H. L., Sobel, R. A. and Kuchroo, V. K. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:3299.
21. Sanderson, C. J. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101.
22. Collins, P. D., Marleau, S., Griffiths-Johnson, D. A., Jose, P. J. and Williams, T. J. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
23. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223.
24. Tran, E. H., Prince, E. N. and Owens, T. 2000. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164:2759.
25. h2-mediated pathologies in autoimmunity. J. Immunol. 167:3074.
26. Segal, B. M., Dwyer, B. K. and Shevach, E. M. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:537.
27. Cua, D. J., Groux, H., Hinton, D. R., Stohlman, S. A. and Coffman, R. L. 1999. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1005.
28. Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E. and Nicholson, L. B. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101.
29. Gran, B., Zhang, G. X., Yu, S., Li, J., Chen, X. H., Ventura, E. S., Kamoun, M. and Rostami, A. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169:7104.
30. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., Zonin, F., Vaisberg, E., Churakova, T., Liu, M., Gorman, D., Wagner, J., Zurawski, S., Liu, Y., Abrams, J. S., Moore, K. W., Rennick, D., de Waal-Malefyt, R., Hannum, C., Bazan, J. F. and Kastelein, R. A. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL. Immunity 13:715.
31. Leonard, J. P., Waldburger, K. E. and Goldman, S. J. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
32. Constantinescu, C. S., Wysocka, M., Hilliard, B., Ventura, E. S., Lavi, E., Trinchieri, G. and Rostami, A. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161:5097.
33. Hjelmstrom, P., Juedes, A. E., Fjell, J. and Ruddle, N. H. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:4480.
34. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. and Fontana, A. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178.
35. Wolf, S. D., Dittel, B. N., Hardardottir, F. and Janeway, C. A., Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271.
36. Lyons, J. A., San, M., Happ, M. P. and Cross, A. H. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432.
37. Lyons, J. A., Ramsbottom, M. J. and Cross, A. H. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905.
38. Svensson, L., Abdul-Majid, K. B., Bauer, J., Lassmann, H., Harris, R. A. and Holmdahl, R. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32:1939.
39. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M. 2002. B cells regulate autoimmunity by provision of IL. Nat. Immunol. 3:944.
40. Johnson, K. P., Brooks, B. R., Ford, C. C., Goodman, A., Guarnaccia, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Pruitt, A., Rose, J. W., Kachuck, N. and Wolinsky, J. S. 2000. Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult. Scler. 6:255.
41. h2-biased response and crossreactivity with myelin basic protein in patients with MS. Mult. Scler. 7:209.
42. h2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170:4483.